Cash Flow Statement

Altimmune (ALT) FCF Margin Growth (3y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 10,029.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 723.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -1,409.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 6,066.00
10 Altimmune 379.61 Mn 379.61 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -809,615.00
Sep 30, 2025 51.76 Mn
Jun 30, 2025 -17.80 Mn
Mar 31, 2025 -29.45 Mn
Dec 31, 2024 -36.46 Mn
Sep 30, 2024 -53.11 Mn
Jun 30, 2024 -34.27 Mn
Mar 31, 2024 -32.43 Mn
Dec 31, 2023 -4.41 Mn
Sep 30, 2023 -533,384.00
Jun 30, 2023 -32.28 Mn
Mar 31, 2023 -9.25 Mn
Dec 31, 2022 -6.64 Mn
Sep 30, 2022 -75.51 Mn
Jun 30, 2022 -20.88 Mn
Mar 31, 2022 -4.22 Mn
Dec 31, 2021 -47,540.00
Sep 30, 2021 -1.12 Mn
Jun 30, 2021 -1.94 Mn
Mar 31, 2021 -268,097.00
Dec 31, 2020 -29,303.00
Sep 30, 2020 -23,268.00
Jun 30, 2020 10,536.00
Mar 31, 2020 93,191.00
Dec 31, 2019 -21,326.00
Sep 30, 2019 4.00 Mn
Jun 30, 2019 8,823.00
Mar 31, 2019 6,323.00
Dec 31, 2018 -5,358.00
Sep 30, 2018 7,106.00
Jun 30, 2018 -22,116.00
Mar 31, 2018 -11,761.00
Dec 31, 2017 -9,291.00
Sep 30, 2017 12,919.00
Jun 30, 2017 -24,268.00
Mar 31, 2017 -106,691.00
Dec 31, 2016 3,679.00
Sep 30, 2016 -4.04 Mn
Jun 30, 2016 -26,385.00
Mar 31, 2016 -13,839.00
Dec 31, 2015 -11,018.00
Sep 30, 2015 -14,175.00
Jun 30, 2015 27,179.00
Mar 31, 2015 -5,176.00
Dec 31, 2014 -17,997.00
Sep 30, 2014 -15,249.00
Jun 30, 2014 446.00
Mar 31, 2014 -2,935.00
Dec 31, 2013 -7,249.00
Sep 30, 2013 503.00